GoKawiil
Daily briefing: AI spread information about an obviously made-up disease
(feeds.nature.com)
31.
32.
Why obesity drugs work better for some people: these genes hold clues
(feeds.nature.com)
33.
Genetics reveal why people respond differently to GLP-1 weight-loss drugs
(feeds.nature.com)
34.
Gilead to Buy German Biotech Tubulis for $3 Billion for Experimental Cancer Drugs
(feeds.content.dowjones.io)
35.
Gen Z wants their job to cover GLP-1 weight-loss drugs, survey suggests
(feeds.feedburner.com)
36.
Chatbots are now prescribing psychiatric drugs
(theverge.com)
38.
39.
Strength persists after a mid-life course of obesity drugs
(feeds.nature.com)
40.
41.
Why smaller portions are the biggest restaurant trend right now
(feeds.feedburner.com)
42.
‘Musclezempic’ Could Be the Future of Weight Loss
(gizmodo.com)
43.
Are obesity drugs causing a severe complication? What the science says
(feeds.nature.com)
46.
This Founder Is Taking a Bite Out of the $50 Billion GLP-1 Market By Going Natural
(feeds.feedburner.com)
47.
Can Ozempic Cure Addiction?
(news.ycombinator.com)
48.
Hims & Hers is scrapping its plan for a knockoff Wegovy weight-loss pill. Here’s why
(feeds.feedburner.com)
49.
GLP-1s Are an Environmental Catastrophe
(futurism.com)
50.
FDA intends to take action against non-FDA-approved GLP-1 drugs
(news.ycombinator.com)
51.
White House launches direct-to-consumer drug site TrumpRx
(news.ycombinator.com)
52.
Novo Nordisk Furious at $49 Knockoff Ozempic Pill
(futurism.com)
53.
Why Cops Frequently Got Caught Planting Drugs in 2017
(gizmodo.com)
54.
55.
56.
ADHD treatments move beyond stimulants
(feeds.nature.com)
57.
Untangling the connection between dopamine and ADHD
(feeds.nature.com)
58.
ADHD is on the rise, but why?
(feeds.nature.com)
59.
This Is How GLP-1 Drugs Are Forcing Restaurant Chains to Change Their Menus
(feeds.feedburner.com)